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Oxytocin (OT) is released into the brain from the cell soma, axons, and dendrites of 
neurosecretory cells in the hypothalamus. Locally released OT can activate OT 
receptors, form inositol-1,4,5-trisphosphate and elevate intracellular free calcium (Ca2+) 
concentrations ([Ca2+]i) in self and neighboring neurons in the hypothalamus, resulting 
in further OT release: i.e., autocrine or paracrine systems of OT-induced OT release. 
CD38-dependent cyclic ADP-ribose (cADPR) is also involved in this autoregulation by 
elevating [Ca2+]i via Ca
2+ mobilization through ryanodine receptors on intracellular Ca2+ 
pools that are sensitive to both Ca2+ and cADPR. In addition, it has recently been 
reported that heat stimulation and hyperthermia enhance [Ca2+]i increases by Ca
2+ influx 
probably through TRPM2 cation channels, suggesting that cADPR and TRPM2 
molecules act as Ca2+ signal amplifiers. Thus, OT release is not simply due to 
depolarization–secretion coupling. Both of these molecules play critical roles not only 
during labor and milk ejection in reproductive females, but also during social behavior 
in daily life in both genders. This was clearly demonstrated in CD38 knockout mice in 
that social behavior was impaired by reduction of [Ca2+]i elevation and subsequent OT 
secretion. Evidence for the associations of CD38 with social behavior and psychiatric 
disorder is discussed, especially in subjects with autism spectrum disorder. 
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Introduction 
Oxytocin (OT) and arginine vasopressin (AVP) are nonapeptides that differ in 
two amino acid residues [1]. OT and AVP are synthesized mostly in distinct 
neurons in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) in 
the hypothalamus [2,3]. OT and AVP are secreted into the blood circulation and 
have physiological roles in peripheral organs, such as the uterus, mammary gland, 
and kidney. They induce contraction of uterine and mammary duct smooth 
muscle or diuretic action in the kidney as hormones [4 – 6].  
OT, AVP, and their receptors are present in the brain not only in females 
during specific reproductive periods but also in non-reproductive females and males [6]. 
Accumulating evidence has established that, in addition to classical hormonal functions, 
both peptides play critical roles in social recognition and social behavior in mammals, 
including humans [7 – 20]. This review focuses mainly on OT. The main point is not a 
general functional role of OT in a comprehensive review, but the molecular mechanisms 
of OT secretion into the brain that is critical in the neuronal function of OT in social 
recognition and behavior [4,11,13,21].  
Another reason to focus on the release is that the mechanism contains a very 
important aspect in the physiological science, in that the proposed idea challenges the 
principal rule in physiology of depolarization–secretion coupling [22 – 24]. Furthermore, 
this mechanism seems to have a potential relationship to autism spectrum disorder 
(ASD), a serious developmental disorder, which is a rapidly advancing field in 
neuroscience and psychiatry and is a serious disorder in our society [25 – 28]. There 
have been many reviews regarding the relationship between ASD and OT [29 – 35]. 
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However, there have been few regarding the molecular mechanism of OT release into 
the brain [4], which is the critical step for social recognition and social behavior [26 – 
28]. 
Somato-axodendritic release of oxytocin  
OT is secreted from the nerve terminals of axons of oxytocinergic neurons at the 
perivascular site in the posterior lobe of the pituitary into the circulation [4] (Figure 1). 
Oxytocinergic neurons send their axons to the amygdala and some other limited brain 
regions and secrete OT from the nerve terminals [4,12,15]. It is known that adrenaline 
stimulates oxytocinergic neurons in the SON, which results in local release of OT in the 
brain [5,36]. This release occurs from the cell soma, axons, and dendrites, i.e., 
somato-axodendritic release [37 – 39]. 
Locally released OT causes excitation of OT neurons by activating OT 
receptors expressed in neurons of both the PVN and SON [40 – 43]. OT stimulates OT 
receptors and facilitates OT release from the stimulated neurons. Released OT can 
stimulate OT receptors and elicits release from the same neurons (autocrine) or nearby 
neurons (paracrine) [44] (Figure 2). This OT-induced OT release determines the basal 
brain concentrations and elevated concentrations of OT. The concept of autoregulation, 
OT-induced OT release, can be an extremely efficient way to achieve massive OT 
recruitment during uterine contraction in labor and milk ejection in lactation [5,6,45 – 
47]. Autoregulation, however, is also an essential brain mechanism for social 





Oxytocin receptors and cellular signaling  
OT receptors are seven-transmembrane proteins that couple with the Gq/11-type 
GTP-binding protein [48]. Stimulation of OT receptors leads to the production of 
inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) through
 the activation of 
phospholipase C (PLC) [48]. This results in activation of Ca2+ mobilization from 
IP3-sensitive Ca
2+ pools [49].  
On the other hand, another Ca2+ signal pathway of cyclic ADP-ribose (cADPR) 
[50,51] was identified downstream of OT receptors [11]. cADPR mobilizes Ca2+ 
through cADPR-sensitive Ca2+ pools, in a mechanism referred to as Ca2+-induced Ca2+ 
release. In this process, cADPR play an essential role in mobilizing Ca2+ through Ca2+ 
channels of ryanodine receptors [52 – 56] (Figure 3). The recent review by Leng et al. 
did not mention this cADPR/CD38 hypothesis [4], probably because they described by 
their data based on their finding with thapsigargin [36]. 
It is known that intracellular cADPR concentrations are regulated in many 
different ways, including activation of ADP-ribosyl cyclase or CD38, via 
heterotrimeric GTP-binding proteins, or phosphorylation downstream of the G 
protein-coupled receptor signaling pathways [57 – 59]. Specifically, the activation of 
ADP-ribosyl cyclase or CD38 by cyclic GMP- or cyclic AMP-dependent protein 
kinases has been reported in Aplysia californica, liver cells [60,61], LAK cells [62,63], 
and artery smooth muscle cells [57] (Figure 3).  
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cADPR is a catalytic product of ADP-ribosyl cyclase or ectopic CD38 [50,51,63] 
(Figure 4). cADPR is produced in the extracellular space by the large N-terminal 
portion of CD38 with catalytic activity that may be present in the extracellular space. 
Therefore, it was unclear how extracellular cADPR produced by CD38 acts as an 
intracellular second messenger. It has been reported that cADPR applied 
extracellularly stimulates intracellular ryanodine receptors after internalization by the 
nucleotide-transporting capacity of CD38 in fibroblasts and astrocytes (the nucleotide 
carrier hypothesis of De Flora) [64,65]. Recently, it was reported that the type II 
transmembrane glycoprotein, CD38, may exist in two forms with regard to membrane 
topology [66,67]; the large N-terminal portion with catalytic activity may exist in the 
extracellular space as the type II protein, and this catalytic site may also exist inside 
the cell as the type III form (Figure 4A). In the latter case, the product of CD38, 
cADPR, is produced intracellularly, and acts directly as a second messenger (two 
topology hypothesis of Lee).  
 
Effects of oxytocin on ADP-ribosyl cyclase and intracellular Ca2+ concentrations 
Application of OT stimulates ADP-ribosyl cyclase activity or CD38 in crude membrane 
fractions, when measured by cADPR formation from -NAD+ or by cyclic GDP-ribose 
(cGDPR) production from NGD+ [50,68]. cADPPR or cGDPR production increases in a 
concentration-dependent manner upon exposure to sub-nanomolar concentrations of OT 
[49].  
Subsequently, in isolated hypothalamic neurons, application of 100 pM OT 
results in [Ca2+]i increases: a rapid initial increase and a sustained elevation lasting for 5 
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minutes [69]. OT elicits an initial elevation of the maximum [Ca2+]i, and this phase is 
IP3-dependent. Pretreatment with 8-bromo-cADPR, an antagonist of the 
cADPR-binding site of Ca2+ release channels of ryanodine, inhibits OT-mediated 
sustained [Ca2+]i increases. ADPR and -NAD+ also induce elevation of [Ca2+]i and 
replicate the second phase of sustained [Ca2+]i increases [49,69]. Under Ca
2+-free 
conditions, the OT-mediated increase of [Ca2+]i shows little change in either phase, 
suggesting that the two phases of [Ca2+]i elevation in hypothalamic neurons are due to 
Ca2+ mobilization from the intracellular Ca2+ pools [49].   
 
Oxytocin release by extracellular application of cyclic ADP-ribose  
High potassium-induced depolarization produces an increase of up to 8-fold in OT 
secretion from isolated mouse hypothalamic neurons or their axon terminals in the 
posterior pituitary gland, respectively [21]. OT release is enhanced by about 4-fold by 
application of extracellular -NAD+, a precursor of cADPR (refer to Figure 4 in Jin et 
al.) [21]. The increase is blocked completely by 8-bromo-cADPR. To further confirm 
the involvement of cADPR, we examined the effects of extracellular application of 
several -NAD+ metabolites [49,69]. Only cADPR showed a potentiation effect, 
indicating that OT release utilizes the cADPR/ryanodine calcium amplification system 
(Figure 5). 
 
Involvement of TRPM2 channels  
Melastatin-related transient receptor potential channel 2 (TRPM2, previously named 
TRPC7 or LTRPC2) possesses ADPR hydrolase activity and is a Ca2+-permeable cation 
channel. -NAD+, ADPR, and cADPR can activate TRPM2 channels [70]. TRPM2 
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activation by cADPR is promoted at body temperature (> 35C) and is involved in 
insulin secretion in pancreatic  cells [71]. In addition, TRPM2 channels are related to 
receptor functions through cADPR formation [72].  
Extracellularly applied cADPR can activate [Ca2+]i signaling via CD38 or 
TRPM2 channels downstream of OT receptors. [Ca2+]i increases in the model neuron, 
NG108-15 mouse neuroblastoma × rat glioma hybrid cells that possess CD38 [58,73] 
but not OT receptors [74], as in the isolated whole hypothalamus after stimulation with 
extracellularly applied cADPR [69,75]. Interestingly, the same tissues show 
significantly greater increases upon extracellular challenge with cADPR together by 
heating to 40°C from 35°C in the incubation medium (Figure 6). Little or no 
cADPR-mediated [Ca2+]i elevation was observed at 40°C in the absence of extracellular 
Ca2+. Ca2+ influx is expected, probably through non-selective cation TRPM2 channels, 
because elevation of [Ca2+]i is inhibited by the TRPM2 channel inhibitor, 
2-aminoethoxydiphenyl borate (2-APB). Similarly, 8-bromo-cADPR inhibits responses 
to -NAD+ and heat. These results suggest that cADPR contributes to both Ca2+ 
mobilization from internal Ca2+ pools and Ca2+ influx through TRPM2 Ca2+-permeable 
channels from the extracellular space. Such [Ca2+]i increases may result in OT release. 
However, there have been no previous reports regarding heat-induced OT release in the 
hypothalamus.  
 
Contribution of CD38 
In the central nervous system, ADP-ribosyl cyclase activity corresponding to CD38 is 
detected as early as embryonic day 15 in mouse development [76]. In the brain, 
expression levels of CD38 and ADP-ribosyl cyclase activity increase with further 
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development [77]. The role of CD38 in regulation of OT secretion through 
cADPR-mediated intracellular calcium signaling has been clearly demonstrated using 
CD38 knockout mice [11,21,78,79]. The plasma and cerebrospinal fluid OT levels are 
reduced in CD38 knockout mice. Electron microscopic examination exhibited little to 
no release from the nerve endings of oxytocinergic neurons in the pituitary of CD38 
knockout mice (Figure 1). These phenotypes were rescued by simple subcutaneous 
injection of OT as well as brain local re-expression of human CD38, but not mutant 
CD38, by the lentivirus infection method in CD38 knockout mice [21].  
 
Human social behavior and psychiatric disorders 
As CD38 is recognized as being closely related to OT release and social memory in 
mice, we examined the association of single nucleotide polymorphisms (SNPs) in the 
human CD38 gene on ASD [80]. In a series of elegant studies in 323 mothers, fathers, 
and non-parents, Epstein and colleagues reported that risk alleles on CD38 (including 
rs3796863) genes are associated with less parental touch. In contrast, relatively high 
plasma OT levels in subjects with low-risk CD38 alleles predict longer durations of 
parent–infant gaze synchrony. Furthermore, parents that display more touch toward their 
infants were reported to have been well cared for in childhood, to exhibit higher plasma 
to levels, and to have low-risk CD38 alleles [29,30,81]. The mother’s CD38 allele 
predicts parental behavioral synchrony at 1 and 6 months of their first-born infants and 
children’s social reciprocity during interactions with their best friend at 3 years. CD38 
in the OT pathway was shown to be critical for parent–infant attachment and attention 
[82]. A SNP on the CD38 gene, is also associated with social integration and social 
connectedness [83]. 
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Several studies indicated the association of CD38 with ASD [84 – 87]. Ten 
SNPs and mutations of CD38 were examined, and the CD38 SNPs, rs6449197 and 
rs3796863, were shown to be linked with high-functioning ASD in participants in the 




This review discussed how OT is released into the brain. Ca2+ influx through Ca2+ 
channels is not sufficient to trigger OT release. The Ca2+ signal must be amplified by 
Ca2+-induced Ca2+ release through Ca2+ channels of ryanodine receptors type II or III by 
cADPR and some NAD metabolites in the hypothalamus (Figure 7). In addition, Ca2+ 
influx through TRPM2 channels contribute more to increases in [Ca2+]i. This hypothesis 
of depolarization-independent but heat-sensitive Ca2+ signaling for OT release is 
consistent with the previous suggestion of dendritic release of OT without 
depolarization [4,21,39]. 
OT exerts an anxiolytic effect during stress, and stress sometimes induces 
hyperthermia. It is therefore interesting to examine how stress induces hyperthermia, 
which results in subsequent OT release. OT release seems to be important in damping 
the stress-induced disadvantage.  
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 OT is an essential molecule for social memory and social behavior [21,29]. 
Deficiency in social behavior is the core symptom of ASD. Recently, Yamasue and his 
group reported that repetitive intranasal OT administration for 6 weeks improved 
symptoms of the social behavior domain [88]. This result could be due to the delivery of 
OT to the brain by intranasal administration, but there is still little direct evidence 
regarding whether OT is recruited into the brain from the peripheral tissues or organs 
crossing the blood–brain barrier from the blood circulation. Several important questions 
regarding OT secretion into the brain and OT-induced Ca2+ signaling and OT transport 
from the blood to the brain remain to be resolved. 
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Figure 1. Electron micrographs of the posterior pituitary glands of wild-type (a) 
and CD38 knockout (b) mice. Vesicles are nerve endings close to the vascular space 
(V). Most of the dense core vesicles are oxytocinergic, as determined by 
immunoelectron microscopic examination. The nerve endings of CD38 knockout mice 
contain more vesicles than those of wild-type mice, indicating that vesicles are released 
in the wild-type mice and not secreted in CD38 knockout mice. Bar, 500 nm. (Modified 
from Figure 3 of Ref. 21) 
 
Figure 2. Scheme showing autocrine and paracrine release of oxytocin. OT is 
released from dendrites (dendritic release), from the cell soma (soma release), and from 
axons (axonal release) in the hypothalamus. Hypothalamic oxytocinergic neurons 
express OT receptors (OTR). Released OT binds to OTR. More OT (yellow circle) is 
released by CD38-mediated intracellular calcium amplification (not shown). The 
positive feedback of OT release occurs by OT released from self or nearby cells via 
autocrine and paracrine mechanisms, respectively.  
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Figure 3. Intracellular signaling pathways leading to increased cyclic ADP-ribose 
formation. Phosphorylation (P) of ADP-ribosyl cyclase (pink) is mediated by several 
pathways. Nitric oxide (NO), cyclic GMP (cGMP), and protein kinase G (G-kinase); 
Acetylcholine (ACh), nicotinic ACh receptors (nAChR); voltage-operated Ca2+ channels 
(VOCC), Ca2 and protein kinase A (A-kinase); norepinephrine (NE),  adrenaline 
receptors (AdR). Activation of CD38 by GTP-binding protein (G protein) and various 
types of receptors triggers formation of cADPR. cADPR opens Ca2 release channels of 
ryanodine receptor type II or III (RyR) with another cofactor, Ca2 (not shown). 
Mobilization of Ca2 from microsomes of Ca2 pools increases [Ca2]i, resulted in OT 
release (not shown). 
 
Figure. 4. Membrane topology and enzyme reaction of CD38. CD38 (pink oval) 
usually forms a dimer. -NAD+ binds to the central catalytic site of CD38. The large 
N-terminal part is located in the extracellular space, as the type II transmembrane 
protein or intracellular space as the type III transmembrane protein, according to Lee 
and colleagues [66,67]. CD38 has three enzymic activities. CD38 catalyzes formation of 
cyclic ADP-ribose from -NAD+ by cleaving nicotinamide. cADPR is hydrolyzed to 
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form ADP-ribose. -NAD+ also has NAD+ glycohydrolase activity to form ADP-ribose 
from -NAD+ in one step. The scheme of enzyme activity is modified from Lee [50]. 
 
Figure 5. Oxytocin induced oxytocin release. Oxytocin (OT; yellow circles) 
stimulates oxytocin receptors (OTR). Subsequently, the Gq/11 type G protein and 
phospholipase C (PLC) are activated, resulting in formation of 
inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). Stimulated protein kinase 
C (PKC) activates CD38 and increases formation of cADPR from -NAD+ inside or 
outside cells. cADPR activates Ca2 influx TRPM2 cation channels. 
2-Aminoethoxydiphenyl borate (2-APB) inhibits TRPM2 channels. IP3 induces 
mobilization of Ca2. TRPM2 mediates Ca2 influx, which also stimulates Ca2 
mobilization through ryanodine receptor Ca2 release channels as a cofactor together 
with cADPR. These Ca2 ions (filled circles) increased by Ca2 amplification mechanisms 
stimulate OXT (yellow) release into the brain, which is an essential step for social 
memory and social behavior. Modified from Higashida et al. [11,27,52,73].  
 
Figure 6. Effects of cyclic ADP-ribose, ADP-ribose, and -NAD+ on heat-induced 
calcium concentration rise. Time course of [Ca2]i changes in Oregon Green-induced 
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anterior hypothalamic neurons. At about 25 s after the beginning of each trace, cells 
were heated from 35°C to 37°C together with 100 M cADPR, ADPR, -NAD+ or 
without nucleotides (heat alone). Symbols indicate changes in [Ca2]i levels, represented 
by the fluorescence intensity at each time point relative to resting intensity at time zero. 
N = 3 – 5 experiments. Mean ± s.e.m. Modified from Liu et al. [69] 
 
Figure 7. Scheme indicating Ca2+ amplification with different ryanodine receptor 
subtypes. Skeletal muscle contraction and heart muscle contraction utilize type I and II 
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